Orthosoft connects its robotic surgery IP to market-facing output through FDA product clearances, demonstrating that development activity reaches the regulatory stage. Their portfolio sits at meaningful scale, backed by consistent research investment. Commercial engagement shows in steady revenue growth alongside those regulatory and research activities, marking a company with an active operational presence in the field. Orthosoft is a wholly owned subsidiary of Zimmer Biomet and files its patents under the Orthosoft name.
